A phase 1/2 trial of a novel viral vector gene therapy in adults with type 1 diabetes is scheduled to begin this year.
Adults with diabetes using an automated insulin delivery system had minimal change in time in range after switching ...
The data did not meet investor expectations, and could bring “fierce investor debate on commercial feasibility,” according to ...
Biomea Fusion, Inc. ( BMEA) Discusses Menin Inhibition Mechanism and Therapeutic Potential in Diabetes March 30, 2026 3:00 PM EDT Michael J. Hitchcock - Interim CEO & Director Ramses Erdtmann - ...
Robinhood is a FINRA and SEC-regulated broker. It plays the role of a bridge that routes customer orders to market makers and ...
1don MSN
Another GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it’s used
The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...
Novo Nordisk is positioned as a durable No. 2 in the obesity drug market, not a loser to Eli Lilly. Click here to read an ...
What you do in your first hour awake can shape how your body feels all day.
YouTube on MSN
The biomarker that ate cardiology
LDL cholesterol (LDL-C) has been elevated to a position of dominance in cardiovascular medicine that is not justified by its ...
Chronic pancreatitis is now recognized as a complex fibroinflammatory disorder involving genetic, environmental, and ...
Weight loss medications like Ozempic, Wegovy, and Mounjaro have been a hot topic these days. We asked the BuzzFeed Community ...
Hua Medicine Announces 2025 Annual Results. Hua Medicine Announces 2025 Annual Results - Annual sales of HuaTangNing exceeded 4 million packs, a year-on-year increase of 91%, with revenues reaching ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results